In the Pipeline: Experimental Drugs and Therapies for Celiac Disease
Francisco Leon, M.D., CSO of Provention Bio, gives an overview of the various drugs and therapies that are currently being developed for the treatment of celiac disease. He explains the celiac community's interest in non-dietary therapies for the disease and which companies are taking on the challenge. He gives a brief overview on the importance of having many drugs being developed at one time. After presenting the various treatments currently going through FDA approval, he focuses on his work with Glutenostics and research regarding AMG 714.